Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 299 institutions that hold shares in the stock, with a total of 91.4 Million shares, which have been reported (via 13F filing form) to have a value of $4.96 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
747,818
shares
|
$40.5 Million
3.91% of portfolio
|
Q3 2025
Reduced 3.42%
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Nov 14, 2025 Q3 2025 |
720,000
shares
|
$39 Million
1.27% of portfolio
|
Q2 2025
Reduced 1.3%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
685,842
shares
|
$37.2 Million
0.01% of portfolio
|
Q3 2025
Reduced 41.37%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
663,442
shares
|
$36 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
643,636
shares
|
$34.9 Million
6.29% of portfolio
|
Q3 2025
Reduced 9.83%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
639,598
shares
|
$34.7 Million
0.16% of portfolio
|
Q3 2025
Reduced 74.08%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
626,526
shares
|
$34 Million
1.99% of portfolio
|
Q3 2025
Reduced 2.19%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
626,019
shares
|
$33.9 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.31%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
612,126
shares
|
$33.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.35%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2025 Q3 2025 |
527,175
shares
|
$28.6 Million
0.03% of portfolio
|
Q3 2025
Reduced 2.52%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
526,200
shares
|
$28.5 Million
0.85% of portfolio
|
Q3 2025
Added 149.03%
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
502,913
shares
|
$27.3 Million
0.04% of portfolio
|
Q3 2025
Added 28.43%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
487,230
shares
|
$26.4 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.66%
|
|
|
Weiss Asset Management LP
Boston, MA |
Nov 14, 2025 Q3 2025 |
486,000
shares
|
$26.3 Million
0.44% of portfolio
|
Q3 2025
Added 1603.71%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
475,400
shares
|
$25.8 Million
1.3% of portfolio
|
Q3 2025
New holding
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2025 Q3 2025 |
473,625
shares
|
$25.7 Million
1.38% of portfolio
|
Q3 2025
Reduced 13.7%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
435,293
shares
|
$23.6 Million
0.38% of portfolio
|
Q3 2025
Added 117.65%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
434,689
shares
|
$23.6 Million
3.28% of portfolio
|
Q2 2025
Added 116.08%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
418,975
shares
|
$22.7 Million
0.01% of portfolio
|
Q3 2025
Added 22.51%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Oct 09, 2025 Q3 2025 |
409,539
shares
|
$22.2 Million
0.02% of portfolio
|
Q3 2025
Reduced 1.89%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 14, 2025 Q3 2025 |
397,010
shares
|
$21.5 Million
2.83% of portfolio
|
Q3 2025
Added 246.57%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
378,858
shares
|
$20.5 Million
0.01% of portfolio
|
Q3 2025
Reduced 2.9%
|
|
|
Summit Partners Public Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
377,152
shares
|
$20.4 Million
0.47% of portfolio
|
Q3 2025
Added 2.77%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
366,784
shares
|
$19.9 Million
0.74% of portfolio
|
Q2 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
339,922
shares
|
$18.4 Million
0.0% of portfolio
|
Q3 2025
Reduced 50.97%
|
|